We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

By Jonathan Stempel NEW YORK (Reuters) -Bristol Myers Squibb won the dismissal of a proposed class action accusing it of ...

Bristol Myers Squibb Co. closed 20.32% short of its 52-week high of $63.33, which the company achieved on March 11th.

Bristol Myers Squibb has received the FDA’s green light to introduce another immunotherapy-based treatment in first-line ...

With data as of April 9, 2025, we examine if Bristol-Myers Squibb Company(BMY) is consistently building momentum based on ...

Bristol-Myers Squibb (NYSE:BMY – Get Free Report) was the target of a significant growth in short interest during the month ...

High-yielding dividend stocks can be great investments to hold on to in your portfolio, but only if they're safe. Betting on ...

Bearish flow noted in Bristol Myers ( BMY) Squibb with 7,624 puts trading, or 1.4x expected. Most active are 5/2 weekly 50 puts and May-25 65 calls, with total volume in those strikes near 5,500 ...

Find out how Bristol Myers Squibb was honored for 50 years of service in Lawrence, from local support to global medical ...

Better-than-expected financial results in recent quarters have signaled an improved outlook, helping to sustain the rally.

Morgan Stanley lowered the firm’s price target on Bristol Myers (BMY) to $36 from $37 and keeps an Underweight rating on the shares. The firm ...

This was the stock's fourth consecutive day of losses.